Heart failure (HF) is a major cause of mortality and morbidity in South Korea, imposing substantial physical, emotional, and financial burdens on patients and society. Despite the high burden of symptom and complex care needs of HF patients, palliative care and hospice services remain underutilized in South Korea due to cultural, institutional, and knowledge-related barriers. This position statement from the Korean Society of Heart Failure emphasizes the need for integrating palliative and hospice care into HF management to improve quality of life and support holistic care for patients and their families. By clarifying the role of palliative care in HF and proposing practical referral criteria, this position statement aims to bridge the gap between HF and palliative care services in South Korea, ultimately improving patient-centered outcomes and aligning treatment with the goals and values of HF patients.

Purpose: Endosseous titanium dental implants are widely regarded as the gold standard for replacing missing teeth. Despite the proven osseointegration of titanium implants, particularly those with enhanced surface modifications, concerns remain regarding esthetics, the risk of peri-implantitis, and potential hypersensitivity. Consequently, alternative materials, such as zirconia, have received increasing attention in recent years. This study evaluated the osseointegration parameters of zirconia implants placed in the mandibles of beagle dogs, as a preliminary in vivo evaluation of zirconia dental implants in South Korea. Materials and Methods: Seven 8-month-old beagle dogs underwent premolar extraction followed by placement of implants in the healed mandibular ridges. The following implants were used in this study: six turned-surface titanium implants, six rough-surface titanium implants, and six zirconia implants, following which the implants and surrounding tissues were harvested en bloc for histological analyses. Bone-to-implant contact (BIC) and new bone area (BA) percentages (%) were calculated and compared between the groups. Statistical analyses were conducted using ANOVA, with the significance level set at p < .05. Results: Histological analysis revealed no statistically significant difference in BIC between the rough-surface titanium and zirconia implants, although the turned-surface titanium implants exhibited significantly lower BIC than the other two groups (p < .05). No significant differences were found among the three groups in terms of BA. Conclusion The results of this study demonstrate that zirconia implants achieve BIC comparable to that of rough-surface titanium implants, suggestive of their potential clinical application.

Purpose: Endosseous titanium dental implants are widely regarded as the gold standard for replacing missing teeth. Despite the proven osseointegration of titanium implants, particularly those with enhanced surface modifications, concerns remain regarding esthetics, the risk of peri-implantitis, and potential hypersensitivity. Consequently, alternative materials, such as zirconia, have received increasing attention in recent years. This study evaluated the osseointegration parameters of zirconia implants placed in the mandibles of beagle dogs, as a preliminary in vivo evaluation of zirconia dental implants in South Korea. Materials and Methods: Seven 8-month-old beagle dogs underwent premolar extraction followed by placement of implants in the healed mandibular ridges. The following implants were used in this study: six turned-surface titanium implants, six rough-surface titanium implants, and six zirconia implants, following which the implants and surrounding tissues were harvested en bloc for histological analyses. Bone-to-implant contact (BIC) and new bone area (BA) percentages (%) were calculated and compared between the groups. Statistical analyses were conducted using ANOVA, with the significance level set at p < .05. Results: Histological analysis revealed no statistically significant difference in BIC between the rough-surface titanium and zirconia implants, although the turned-surface titanium implants exhibited significantly lower BIC than the other two groups (p < .05). No significant differences were found among the three groups in terms of BA. Conclusion The results of this study demonstrate that zirconia implants achieve BIC comparable to that of rough-surface titanium implants, suggestive of their potential clinical application.

Purpose: Endosseous titanium dental implants are widely regarded as the gold standard for replacing missing teeth. Despite the proven osseointegration of titanium implants, particularly those with enhanced surface modifications, concerns remain regarding esthetics, the risk of peri-implantitis, and potential hypersensitivity. Consequently, alternative materials, such as zirconia, have received increasing attention in recent years. This study evaluated the osseointegration parameters of zirconia implants placed in the mandibles of beagle dogs, as a preliminary in vivo evaluation of zirconia dental implants in South Korea. Materials and Methods: Seven 8-month-old beagle dogs underwent premolar extraction followed by placement of implants in the healed mandibular ridges. The following implants were used in this study: six turned-surface titanium implants, six rough-surface titanium implants, and six zirconia implants, following which the implants and surrounding tissues were harvested en bloc for histological analyses. Bone-to-implant contact (BIC) and new bone area (BA) percentages (%) were calculated and compared between the groups. Statistical analyses were conducted using ANOVA, with the significance level set at p < .05. Results: Histological analysis revealed no statistically significant difference in BIC between the rough-surface titanium and zirconia implants, although the turned-surface titanium implants exhibited significantly lower BIC than the other two groups (p < .05). No significant differences were found among the three groups in terms of BA. Conclusion The results of this study demonstrate that zirconia implants achieve BIC comparable to that of rough-surface titanium implants, suggestive of their potential clinical application.

Purpose: B-cell depleting therapies, including T-cell engager (TCE), are increasingly used for patients with hematologic malignancies, including during the coronavirus disease 2019 (COVID-19) pandemic. We aimed to evaluate the relationship between TCE therapy and COVID-19–related outcomes among patients with COVID-19 and B-cell lymphomas receiving B-cell depleting therapy. Materials and Methods: This retrospective cohort study included patients with B-cell lymphoma, who were admitted to Seoul Natio-nal University Hospital with COVID-19 between September 2021 and February 2023, and received B-cell depleting therapy before COVID-19 diagnosis. Multivariable logistic regression was used to identify factors associated with severe to critical COVID-19 and COVID-19–related mortality. Results: Of 54 patients with B-cell lymphomas and COVID-19 who received B-cell depleting therapy, 14 were treated with TCE (TCE group) and 40 with rituximab (RTX group). COVID-19–related mortality was higher in the TCE group than in the RTX group (57.1% vs. 12.5%, p=0.002). In multivariable analyses, TCE therapy (adjusted odds ratio [aOR], 7.08; 95% confidence interval [CI], 1.29 to 38.76; p=0.024) and older age (aOR, 1.06; 95% CI, 1.00 to 1.13; p=0.035) were associated with severe to critical COVID-19. TCE therapy (aOR, 8.98; 95% CI, 1.48 to 54.40; p=0.017), older age (aOR, 1.13; 95% CI, 1.02 to 1.26; p=0.022), and prior bendamustine therapy (aOR, 7.78; 95% CI, 1.17 to 51.65; p=0.034) were independent risk factors for COVID-19–related mortality. Conclusion B-cell lymphoma patients treated with TCE had significantly worse outcomes from COVID-19 than those treated with RTX. TCE therapy should be used with caution in B-cell lymphoma patients during the COVID-19 epidemic.

Background: Currently, there is no consensus on the treatment of psoriasis in Korean patients. Objective: This study aimed to establish a consensus on the basic therapeutic principles for Korean patients with plaque psoriasis. Methods: Using the modified Delphi method, a steering committee proposed 53 statements for the first Delphi round, which covered five subjects: (1) the goal of treatment and evaluation of disease severity, (2) topical therapy, (3) phototherapy, (4) conventional systemic therapy, and (5) biologic therapy. The panel of dermatologists scored the level of agreement for each statement on a ten-point scale with scores ranging from 1 (strongly disagree) to 10 (strongly agree). After discussing the results of the first round, the committee reformulated 41 statements. Finally, consensus was defined as more than 70% of the second round scores being ≥7. Results: The panel participants strongly agreed that the ideal treatment goals for Korean patients with plaque psoriasis should include complete skin clearance and high dermatological quality of life. A strong consensus was also reached on the use of topical agents for psoriasis of any severity, the consideration of phototherapy before biologics therapy, the conventional systemic agents for moderate-to-severe psoriasis, and the recommendation of biologic for retractable psoriasis to conventional systemic therapy and phototherapy. Conclusion This modified Delphi panel established an expert consensus on the therapeutic approach for Korean patients with plaque psoriasis. This consensus may improve the treatment outcomes for psoriasis in Korea.

BACKGROUND: Cardiovascular risk remains increased despite optimal low density lipoprotein cholesterol (LDL-C) level induced by intensive statin therapy. Therefore, recent guidelines recommend non-high density lipoprotein cholesterol (non-HDL-C) as a secondary target for preventing cardiovascular events. The aim of this study was to assess the efficacy and tolerability of omega-3 fatty acids (OM3-FAs) in combination with atorvastatin compared to atorvastatin alone in patients with mixed dyslipidemia. METHODS: This randomized, double-blind, placebo-controlled, parallel-group, and phase III multicenter study included adults with fasting triglyceride (TG) levels ≥200 and <500 mg/dL and LDL-C levels <110 mg/dL. Eligible subjects were randomized to ATOMEGA (OM3-FAs 4,000 mg plus atorvastatin calcium 20 mg) or atorvastatin 20 mg plus placebo groups. The primary efficacy endpoints were the percent changes in TG and non-HDL-C levels from baseline at the end of treatment. RESULTS: After 8 weeks of treatment, the percent changes from baseline in TG (−29.8% vs. 3.6%, P<0.001) and non-HDL-C (−10.1% vs. 4.9%, P<0.001) levels were significantly greater in the ATOMEGA group (n=97) than in the atorvastatin group (n=103). Moreover, the proportion of total subjects reaching TG target of <200 mg/dL in the ATOMEGA group was significantly higher than that in the atorvastatin group (62.9% vs. 22.3%, P<0.001). The incidence of adverse events did not differ between the two groups. CONCLUSION The addition of OM3-FAs to atorvastatin improved TG and non-HDL-C levels to a significant extent compared to atorvastatin alone in subjects with residual hypertriglyceridemia.

PURPOSE: As the Korean population ages, an increasing number of elderly patients with gastric cancer are undergoing surgical resection. The aim of this study was to analyze the surgical outcomes and prognostic factors after gastric cancer surgery for patients 80 years of age or older.METHODS: We analyzed the medical records of 720 patients with gastric cancer who underwent gastrectomy from March 2010 to December 2014 retrospectively. Patients were divided into two groups: octogenarians (age ≥80 years, n=46) and non-octogenarians (age <80 years, n=674). We evaluated clinicopathologic data including postoperative morbidity, mortality, and 5-year survival rate.RESULTS: The rate of curative resection was not different between the two groups. The American Society of Anesthesiology score was significantly higher in the octogenarians (P<0.05). Octogenarians exhibited poorer performance scale scores, higher comorbidities, and more advanced TNM stages than non-octogenarians. There was no difference in surgical resection margins between the two groups. In addition, octogenarians suffered from more postoperative morbidity and mortality than non-octogenarians. In the analysis of risk factors of survival after gastrectomy for octogenarians, advanced TNM stage and dose of transfusion were independent risk factors. Overall survival was significantly lower in octogenarians than non-octogenarians. There was no difference in the disease-specific survival for each stage of cancer after adjustment for tumor stage.CONCLUSION: Octogenarians had more preoperative risk factors and postoperative morbidity and mortality, but cancer-specific survival was comparable with non-octogenarians. Careful preoperative evaluation, thorough resection, and attentive postoperative care can improve the overall survival of octogenarians with gastric cancer.
Aged ; Aged, 80 and over ; Anesthesiology ; Comorbidity ; Gastrectomy ; Humans ; Medical Records ; Mortality ; Postoperative Care ; Retrospective Studies ; Risk Factors ; Stomach Neoplasms ; Survival Rate ; Treatment Outcome

OBJECTIVE: We evaluated the clinical characteristics and prognoses of patients with septic shock who transferred to the emergency department (ED) in a tertiary referral center. METHODS: This study was performed using a prospective, multi-center registry of septic shock, with the participation of 11 tertiary referral centers in the Korean Shock Society between October 2015 and February 2017. We classified the patients as a transferred group who transferred from other hospitals after meeting the inclusion criteria upon ED arrival and a non-transferred group who presented directly to the ED. Primary outcome was hospital mortality. We conducted multiple logistic regression analysis to assess variables related to in-hospital mortality. RESULTS: A total of 2,098 patients were included, and we assigned 717 patients to the transferred group and 1,381 patients to the non-transferred group. The initial Sequential Organ Failure Assessment score was higher in the transferred group than the non-transferred group (6; interquartile range [IQR], 4–9 vs. 6; IQR, 4–8; P < 0.001). Mechanical ventilator (29% vs. 21%, P < 0.001) and renal replacement therapy (12% vs. 9%, P=0.034) within 24 hours after ED arrival were more frequently applied in the transferred group than the non-transferred group. Overall hospital mortality was 22% and there was no significant difference between transferred and non-transferred groups (23% vs. 22%, P=0.820). Multivariable analysis showed an odds ratio for in-hospital mortality of 1.00 (95% confidence interval, 0.78–1.28; P=0.999) for the transferred group compared with the non-transferred group. CONCLUSION: The transferred group showed higher severity and needed more organ support procedures than the nontransferred group. However, inter-hospital transfer did not affect in-hospital mortality.
Emergencies* ; Emergency Service, Hospital* ; Hospital Mortality ; Humans ; Logistic Models ; Mortality ; Observational Study* ; Odds Ratio ; Prognosis ; Prospective Studies ; Renal Replacement Therapy ; Retrospective Studies* ; Sepsis ; Shock ; Shock, Septic* ; Tertiary Care Centers* ; Ventilators, Mechanical

BACKGROUND: The bispectral index (BIS) is a valuable indicator for measuring sedation levels and patient consciousness. Recent reports have highlighted its clinical value as an indicator for anesthesia-related cerebral hypoperfusion and ischemic brain damage. CASE REPORT: A 55-year-old female patient underwent right breast conservation surgery during general anesthesia. During surgery, the patient experienced abrupt bradycardia (heart rate of 36 bpm) without hypotension. During bradycardia, her BIS was severely reduced from 45 to 20 along with elvated suppression ratio (50). After injection of 0.5mg of atropine, her BIS level was recovered, her heart rate was increased, and her suppression ratio was decreased. CONCLUSION: The patient recovered from anesthesia without showing any signs of neurological sequelae based on BIS level monitoring.
Anesthesia ; Anesthesia, General ; Atropine ; Bradycardia ; Brain ; Breast ; Consciousness ; Consciousness Monitors ; Female ; Heart Rate ; Humans ; Hypotension ; Mastectomy, Segmental ; Middle Aged